Torrent Pharmaceuticals Limited (TORNTPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.123x

Based on the latest financial reports, Torrent Pharmaceuticals Limited (TORNTPHARM) has a cash flow conversion efficiency ratio of 0.123x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs10.38 Billion ≈ $112.26 Million USD) by net assets (Rs84.49 Billion ≈ $913.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Torrent Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Torrent Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Torrent Pharmaceuticals Limited carry for a breakdown of total debt and financial obligations.

Torrent Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Torrent Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Sprott Physical Silver
TO:PSLV
0.006x
CF Industries Holdings Inc
NYSE:CF
0.138x
Azrieli Group Ltd
TA:AZRG
0.017x
Rogers Communications Inc
TO:RCI-B
0.072x
Ningbo Tuopu Group Co Ltd
SHG:601689
0.022x
Falabella
SN:FALABELLA
0.018x
LI AUTO INC. (SP.ADR)/2
F:L87A
N/A
VODACOM GROUP LTD. SP.ADR
F:5VD0
N/A

Annual Cash Flow Conversion Efficiency for Torrent Pharmaceuticals Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Torrent Pharmaceuticals Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see TORNTPHARM market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs75.91 Billion
≈ $820.94 Million
Rs25.85 Billion
≈ $279.56 Million
0.341x -28.51%
2024-03-31 Rs68.56 Billion
≈ $741.47 Million
Rs32.66 Billion
≈ $353.21 Million
0.476x +24.69%
2023-03-31 Rs61.98 Billion
≈ $670.29 Million
Rs23.68 Billion
≈ $256.09 Million
0.382x +26.14%
2022-03-31 Rs59.53 Billion
≈ $643.79 Million
Rs18.03 Billion
≈ $194.99 Million
0.303x -12.07%
2021-03-31 Rs58.37 Billion
≈ $631.27 Million
Rs20.11 Billion
≈ $217.45 Million
0.344x +19.37%
2020-03-31 Rs48.23 Billion
≈ $521.61 Million
Rs13.92 Billion
≈ $150.52 Million
0.289x -24.18%
2019-03-31 Rs47.24 Billion
≈ $510.92 Million
Rs17.98 Billion
≈ $194.46 Million
0.381x +96.76%
2018-03-31 Rs46.23 Billion
≈ $499.93 Million
Rs8.94 Billion
≈ $96.70 Million
0.193x -16.90%
2017-03-31 Rs43.51 Billion
≈ $470.50 Million
Rs10.13 Billion
≈ $109.52 Million
0.233x -70.92%
2016-03-31 Rs33.89 Billion
≈ $366.56 Million
Rs27.13 Billion
≈ $293.43 Million
0.800x +146.11%
2015-03-31 Rs24.91 Billion
≈ $269.39 Million
Rs8.10 Billion
≈ $87.62 Million
0.325x +3.25%
2014-03-31 Rs19.03 Billion
≈ $205.78 Million
Rs5.99 Billion
≈ $64.82 Million
0.315x +191.92%
2013-03-31 Rs14.22 Billion
≈ $153.82 Million
Rs1.53 Billion
≈ $16.60 Million
0.108x -74.53%
2012-03-31 Rs11.97 Billion
≈ $129.49 Million
Rs5.07 Billion
≈ $54.87 Million
0.424x +9.98%
2011-03-31 Rs10.24 Billion
≈ $110.74 Million
Rs3.95 Billion
≈ $42.67 Million
0.385x +11.56%
2010-03-31 Rs8.31 Billion
≈ $89.87 Million
Rs2.87 Billion
≈ $31.04 Million
0.345x -12.83%
2009-03-31 Rs6.51 Billion
≈ $70.39 Million
Rs2.58 Billion
≈ $27.89 Million
0.396x -16.47%
2008-03-31 Rs5.10 Billion
≈ $55.11 Million
Rs2.42 Billion
≈ $26.14 Million
0.474x +164.43%
2007-03-31 Rs4.10 Billion
≈ $44.37 Million
Rs735.97 Million
≈ $7.96 Million
0.179x +81.59%
2006-03-31 Rs3.48 Billion
≈ $37.62 Million
Rs343.63 Million
≈ $3.72 Million
0.099x +23.72%
2005-03-31 Rs3.16 Billion
≈ $34.12 Million
Rs251.96 Million
≈ $2.72 Million
0.080x --

About Torrent Pharmaceuticals Limited

NSE:TORNTPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$15.32 Billion
Rs1.42 Trillion INR
Market Cap Rank
#1583 Global
#49 in India
Share Price
Rs4185.10
Change (1 day)
-1.10%
52-Week Range
Rs3127.80 - Rs4446.00
All Time High
Rs4446.00
About

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nep… Read more